Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1215 of 5804
-
New app aims to give teens with suicidal thoughts a lifeline
Symptom relief Recruiting nowThe goal of this clinical trial is to evaluate an app to help keep teens and young adults with suicidal thoughts safe. The app includes a safety plan created by adolescents and healthcare providers, and videos to encourage supportive communication and skills for teens and young a…
Phase: NA • Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
New diabetes pill shows promise in Mid-Stage trial
Disease control OngoingThis multicenter, randomized, double-blind, placebo- and open-label active comparator-controlled, parallel-group, dose-range-finding, Phase II study aims to evaluate the efficacy, tolerability, and safety of RO7795081 for glycemic control in adult participants with Type 2 diabete…
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Exercise and drug combo may fight chemo brain fog
Symptom relief Recruiting nowThis randomized, placebo-controlled trial aims to assess the feasibility, acceptability, and preliminary efficacy of memantine and the University of Carolina (UNC)'s Get Real \& Heel cancer exercise program (MEM+EX) in addressing cancer-related cognitive impairment (CRCI) and und…
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Glow-in-the-Dark dye helps surgeons spot hidden cancer
Diagnosis Recruiting nowThe goal of clinical trial is to test an FDA approved drug called Pafolacianine that attaches to cancer cells and lights up when seen through a special camera system in adults with a suspected primary diagnosis, or a high clinical suspicion of gastrointestinal, fore gut, pancreat…
Phase: PHASE2 • Sponsor: John Waters • Aim: Diagnosis
Last updated Jun 27, 2026 13:02 UTC
-
Could a multiple sclerosis drug help treat a bleeding disorder?
Disease control Recruiting nowA multicenter, open-label, randomized study to report the efficacy and safety of teriflunomide plus high-dose dexamethasone compared to high-dose dexamethasone monotherapy for the first-line treatment of adults with newly diagnosed primary immune thrombocytopenia (ITP).
Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 26, 2026 14:37 UTC
-
Teamwork and tech take on type 1 diabetes in new trial
Disease control Recruiting nowThe GLITTER Study 2 is a cluster randomized trial that will evaluate the impact of comprehensive and intensive management, comprising a team, technology, education, and peer resources, on metabolic control and psychological outcomes in patients with type 1 diabetes.
Phase: NA • Sponsor: Second Xiangya Hospital of Central South University • Aim: Disease control
Last updated Jun 26, 2026 12:49 UTC
-
Can a phone app help people with HIV kick the smoking habit?
Disease control Recruiting nowThe purpose of this study is to compare the advantages and disadvantages of two approaches for quitting smoking among people living with HIV (PWH). Participants will complete a 24- week (\~6-month) study where the Participants will be assigned to one of two smartphone apps to hel…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New antibody combo takes on Hard-to-Treat myeloma
Disease control ENROLLING_BY_INVITATIONThe goal of this clinical trial is to learn if the antibody drug HuL001, combined with Lenalidomide/Dexamethasone works to treat Multiple Myeloma patients. It will also learn about the safety and tolerability of the therapeutic combination. The objectives of this study are: 1. …
Phase: PHASE1, PHASE2 • Sponsor: HuniLife Biotechnology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Can a herbal sachet beat chemo fatigue? new trial aims to find out
Symptom relief Recruiting nowThe goal of this clinical trial is to evaluate whether Nuvastatic can reduce cancer-related fatigue in adult patients with colon cancer undergoing first-line chemotherapy. The main questions it aims to answer are: Does Nuvastatic significantly reduce cancer-related fatigue comp…
Phase: PHASE3 • Sponsor: Natureceuticals Sdn Bhd • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Could a flickering light headset lift depression?
Symptom relief Recruiting nowThis pilot study evaluates the feasibility, safety, and preliminary efficacy of home-based 60Hz intermittent light therapy in adults with a major depressive episode (MDE). Participants will be randomized in a 2:1 ratio to receive either active or sham 60Hz intermittent light stim…
Phase: NA • Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
New Needle-Free blood draw device could slash contamination and pain in ERs
Disease control Recruiting nowBlood cultures (BCs) are a blood test to look for an infection. Two problems with the sample collection are contamination by germs outside of the blood and not collecting enough blood in the tube, resulting in unusable samples. Many patients requiring a BC also have a peripheral …
Phase: NA • Sponsor: The University of Queensland • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Heart drug showdown: which Beta-Blocker best protects ICD patients?
Disease control Recruiting nowThis prospective, multicenter, open-label, randomized comparative effectiveness trial, titled CARVTOP-ICD, evaluates the impact of carvedilol versus metoprolol succinate in patients with heart failure with reduced ejection fraction (HFrEF) and an implantable cardioverter defibril…
Phase: PHASE4 • Sponsor: University of Rochester • Aim: Disease control
Last updated Jun 26, 2026 18:20 UTC
-
Immunotherapy drug cemiplimab takes on rare, incurable cancer
Disease control Recruiting nowThis phase II trial studies how well cemiplimab works in treating patients with nuclear protein of testis (NUT) carcinoma for which no treatment is currently available (incurable) and that has spread from where it first started (primary site) to other places in the body (metastat…
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
AI could prevent bile duct injuries in gallbladder surgery
Diagnosis Recruiting nowLaparoscopic cholecystectomy is a common surgical procedure, but it carries the potential for bile duct injury and other surgical risks. To provide visual assistance to surgeons during surgery and mitigate these risks, this research project aims to develop a real-time object reco…
Sponsor: Chinese Academy of Sciences • Aim: Diagnosis
Last updated Jun 26, 2026 13:34 UTC
-
New hope for kids with rare brain tumors: experimental drug enters human testing
Disease control Recruiting nowThis is a phase I, open-label, dose-escalation and expansion study to evaluate the safety, tolerability, PK of HSK42360 when given orally in pediatric patients with active BRAF V600 mutation recurrent malignant brain tumors.
Phase: PHASE1 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 15:15 UTC
-
Targeted radiation drug takes aim at bone metastases in early trial
Disease control Recruiting nowA multicenter, open-label Phase I clinical trial to evaluate the safety, tolerability, pharmacokinetics, dosimetry and efficacy of SKB107 in subjects with advanced solid tumors with bone metastases.
Phase: PHASE1 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New pill could melt fat in people with obesity
Disease control OngoingThis is a randomized, double-blind, placebo-controlled study evaluating the effects of aleniglipron on body composition in participants living with obesity. Participants will be randomized to aleniglipron or placebo in a ratio of 5:1. Participants will receive multiple ascending …
Phase: PHASE2 • Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Virtual reality boosts arm recovery in stroke patients
Symptom relief Recruiting nowStroke ranks second among the leading causes of death worldwide and third among the causes of disability. In stroke patients, motor impairment typically affects facial movements and the upper and lower extremities unilaterally. Upper extremity involvement, in particular, negative…
Phase: NA • Sponsor: Istanbul Physical Medicine Rehabilitation Training and Research Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
New IVIG therapy V-IMMUNE tested in phase III trial for immune deficiency
Disease control Recruiting nowThis is a phase III, non-randomized clinical trial (VIP Study) designed to assess the safety and efficacy of V-IMMUNE®, a 5% human normal immunoglobulin preparation, in approximately 50 patients with primary immunodeficiency (PID). Participants, all aged ≥2 years and already rece…
Phase: PHASE3 • Sponsor: On Pharma Importadora, Exportadora e Distribuidora de Medicamentos LTDA. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
AI model aims to end guesswork in head and neck cancer care
Knowledge-focused ENROLLING_BY_INVITATIONBased on multimodal data, the investigators establish a dynamic deep learning model to conduct prognostic risk assessment for patients and recommend the 'most suitable' treatment/follow-up regimen after radical treatment, assisting clinicians in improving homogenized evaluation l…
Sponsor: Nanfang Hospital, Southern Medical University • Aim: Knowledge-focused
Last updated Jul 22, 2026 00:00 UTC